Canton Strategic Holdings, Inc.

CNTN

Digital assets

$2.16vs prev close▼-0.04(-1.60%)

$1.7552W Range$9.08

6% from low

+0.25 (+12.89%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

No trades in 1M

1M net buy

≈ 0 shares

Portfolio Weight

0.01%

1M 0.00%p

Holding ETFs

1 ETFs

ARKF

Price Effect (Sell)

Shares decreased, but price appreciation increased portfolio weight.

Shares -3.8% · Market value -28.8% · Weight 0.00%p

Trade Intensity

No trades in 1M

Trade Log

Date	Action	ETF	Shares	Close	Est. total
26.03.12	BUY	ARKF	54,736	$4.20	$229.6K
26.03.09	BUY	ARKF	37,485	$4.45	$166.8K
26.03.06	BUY	ARKF	42,500	$4.48	$190.4K
26.03.05	BUY	ARKF	93,900	$4.50	$422.6K
26.03.04	BUY	ARKF	32,156	$4.68	$150.5K
26.02.23	BUY	ARKF	2,800	$4.89	$13.7K
26.02.19	BUY	ARKF	21,462	$4.51	$96.8K

03.12BUY

54,736

ARKFClose$4.20Est. total$229.6K

03.09BUY

37,485

ARKFClose$4.45Est. total$166.8K

03.06BUY

42,500

ARKFClose$4.48Est. total$190.4K

03.05BUY

93,900

ARKFClose$4.50Est. total$422.6K

03.04BUY

32,156

ARKFClose$4.68Est. total$150.5K

02.23BUY

2,800

ARKFClose$4.89Est. total$13.7K

02.19BUY

21,462

ARKFClose$4.51Est. total$96.8K

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

390,059

Portfolio Weight

0.01%

in ETF 0.1%

Est. Value

$741K

30D Net

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

No analyst data available

Price Information

Previous Close$2.21

Open$2.22

Day Range$2.13 - $2.23

52-Week Range$1.75 - $9.08

1-Year Change-71.60%

Trading Volume

Volume718,089

Avg Volume (3mo)969,791

Valuation

Market Cap174.5M

Book Value$5.89

Shares Outstanding79,681,361

Financials

Revenue (TTM)1.5M

Net Income-96,094,728

EPS$-0.15

EBITDA-

Profitability

P/E Ratio-

P/B Ratio0.37

Return on Equity (ROE)-42.21%

Return on Assets (ROA)-11.69%

Profit Margin0.00%

EV/EBITDA-

Beta1.47

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)67.59

Company Overview

Canton Strategic Holdings, Inc. is focused on advancing institutional blockchain adoption and financial market digitization through its Canton Coin and network. The company is also developing innovative pharmaceutical technologies, including GV104 for respiratory/nervous system depression and GV023, an oral formulation of infliximab, aiming to improve treatment accessibility and reduce burden.

P/B

0.37

Below book value

ROE

-42.2%

Persistent loss

Beta

1.47

Market Volatility

RSI(14)

67.6

Neutral zone

AI-generated summary. Not investment advice.